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Abnormal uterine bleeding needs surgical treatment if medical therapy fails. After introduc-
tion of non-hysteroscopic endometrial ablation as alternative to hysteroscopic endometrial
resection, we aimed to compare short and long-term outcomes for women treated with
these two minimally-invasive procedures. A secondary goal was comparing the present
cohort to a previous cohort of women treated with hysteroscopic resection only.
Materials and methods
Historical cohort study of women treated for abnormal uterine bleeding with hysteroscopic
resection or endometrial ablation at Haukeland University Hospital during 2006–2014. Simi-
lar patient file and patient-reported outcome data were collected from 386 hysteroscopic
resections in a previous cohort (1992–1998). Categorical variables were compared by Chi-
square or Fisher´s Exact-test, linear variables by Mann-Whitney U-test and time to hysterec-
tomy by the Kaplan-Meier method.
Results
During 2006–2014, 772 women were treated with endometrial resection or ablation, 468
women (61%) consented to study-inclusion; 333 women (71%) were treated with hystero-
scopic resection and 135 (29%) with endometrial ablation.
Preoperative characteristics were significantly different for women treated with hystero-
scopic resection compared to endometrial ablation in the 2006-2014-cohort and between
the two time-cohorts regarding menopausal, sterilization and myoma status (p�0.036). The
endometrial ablation group had significantly shorter operation time, median 13 minutes
(95% Confidence Interval (CI) 12–14) and a lower complication rate (2%) versus operation
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time, median 25 minutes (95% CI 23–26) and complication rate (13%) in the hysteroscopy
group, all p�0.001. The patient-reported rate of satisfaction with treatment was equivalent
in both groups (85%, p = 0.955). The endometrial ablation group had lower hysterectomy
rate (8% vs 16%, p = 0.024). Patient-reported satisfaction rate was higher (85%) in the
2006-2014-cohort compared with the 1992-1998-cohort (73%), p<0.001.
Conclusions
Endometrial ablation has similar patient satisfaction rate, but shorter operation time and
lower complication rate and may be a good alternative to hysteroscopic resection for treat-
ment of abnormal uterine bleeding.
Introduction
Menorrhagia is a significant health problem in premenopausal women, with an estimated
annual incidence for seeking medical help of 10/1000 women years [1, 2]. Menorrhagia can
reduce quality of life, and cause iron deficiency anemia [3]. Treatment of menorrhagia and
reversal of anemia gives an increased quality of life [4].
When specific causes of abnormal uterine bleeding such as endometrial polyps, endome-
trial neoplasia or hematologic bleeding disorders have been excluded, treatment may be initi-
ated. First-line treatment has traditionally consisted of medical therapy such as progestin,
either as an oral medication or as a hormone-releasing intrauterine device (IUD). However,
medical therapy is often ineffective. A systematic 2016 Cochrane review revealed that 59% of
women randomized to receive medical treatment for abnormal uterine bleeding underwent
surgery within two years, and 77% after five years [5]. A study by Famuyide from 2017 con-
cluded that initial radiofrequency endometrial ablation compared to medical therapy offered
superior reduction in menstrual blood loss and improvement in quality of life without signifi-
cant differences in total costs of care [6].
Hysterectomy is a definitive treatment of the bleeding disorder but is costly and associated
with a considerable risk of severe complications [7, 8]. During the 1980s, less invasive surgical
procedures were developed; removal or destruction of the endometrium while preserving the
uterus.
Following the first hysteroscopic procedures, several non-hysteroscopic endometrial abla-
tion methods have evolved during the last 25 years, including thermal balloon ablation, micro-
wave ablation, free-fluid thermal ablation, bipolar radiofrequency ablation and cryotherapy.
These newer techniques are generally quicker, have lower complication rates and are techni-
cally less demanding, allowing a more widespread use of endometrial ablation techniques [7,
9, 10].
We have earlier evaluated a large cohort of 386 patients treated with hysteroscopic resection
during the time-period 1992–1998 in our department [11]. A bipolar radiofrequency endome-
trial ablation method was introduced as an alternative to hysteroscopic resection in our depart-
ment in 2004. When altering treatment regimes, and specifically when introducing a new
surgical modality, it is important to evaluate if this change is beneficial.
Hence, the objectives of this study were to evaluate the outcomes of two different minimally
invasive techniques for treating abnormal menstrual bleeding in our department in the
period 2006–2014, and to compare the results with a previous cohort of hysteroscopic resec-
tions only.
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Materials and methods
In this historical cohort study patients were identified from the electronic patient files from
Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway.
We included all patients with a Nordic Classification of Surgical Procedures (NCSP) code LCB
25 (Hysteroscopic excision of lesion), LCB28 (Hysteroscopic endometrial excision) or LCA16
(Endometrial destruction) treated during the period 2006–2014 [12]. Regarding procedure
LCB25, excisions performed on polyps or uterine septa were excluded. The surgical indication
for the vast majority of patients was menorrhagia unresponsive to medical treatment. Accord-
ing to the department guidelines, the uterine cavity length should be less than 12 cm and sub-
mucosal fibroids should be less than 5 cm, evaluated by preoperative transvaginal ultrasound.
Submucosal fibroid distorting the cavity was an exclusion criterion for endometrial ablation.
Endometrial samples were collected from all patients prior to surgery to exclude neoplasia. In
general, no specific medical pre-treatment regimen was used.
All procedures were performed under general anesthesia or spinal block. The endometrial
ablation procedures also included a paracervical nerve block. The endometrial resections were
performed using a rigid 9 mm hysteroscope, bipolar loop diathermy and isotonic (0.9%) saline.
The endometrial ablation procedures were performed using NovaSure1 Endometrial Abla-
tion System, (Hologic, Marlborough, Massachusetts, USA) a 6 mm diameter probe using bipo-
lar radiofrequency diathermy for vaporization and coagulation.
We reviewed hospital records for patient information. Preoperative data included age, par-
ity, if sterilization had been performed, preoperative medical treatment, symptoms, and ultra-
sound findings. Perioperative data included type of procedure, operation time and
complications. Any repeat procedure or subsequent hysterectomy was noted. Between two
and nine years after surgery, patients were mailed a questionnaire (S1 Fig and S2 Fig) with
questions regarding short-term (<one month post-operative) and long-term (>one month
post-operative) effects of treatment. Patient self-report of overall satisfaction rate finalized the
questionnaire.
For peri- and postoperative analysis, the procedures were categorized into two groups: hys-
teroscopic endometrial resection with or without resection of fibroids and bipolar radiofre-
quency endometrial ablation. In the logistic regression assessing risk of subsequent
hysterectomy, cases with only myoma resection performed were excluded, as this primarily is
a fertility sparing treatment as opposed to full endometrial resection/ablation.
Events registered as complications were: discontinued procedure, uterine perforation, fluid
deficiency >1000ml and bleeding (defined as>500ml or bleeding with the need of additional
hemostatic treatment such as internal uterine compression by catheter balloon or intravenous
antifibrinolytic medication).
We classified surgeons in three categories; as experienced (>50 procedures), medium expe-
rienced (10–50 procedures), or inexperienced (<10 procedures).
For comparison, and evaluation of our present treatment algorithm, we used data from a
previous study of women treated with endometrial resection during the period 1992–1998
[11]. Data collection (from patient files and patient questionnaire), inclusion criteria and defi-
nitions have been exactly the same for both cohorts.
Statistical analyses were performed using the statistical package in SPSS version 25, IBM,
Armonk, New York, USA. Categorical variables were compared by Chi-square test or Fisher
exact test. Linear variables were compared by non-parametrical tests, Mann-Whitney U-test
or Kruskal-Wallis test. Survival analysis regarding time until reoperation/hysterectomy by the
Kaplan-Meier log rank method were applied to compare the two different operative proce-
dures and to compare the two time cohorts. Logistic regression assessing risk of later
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hysterectomy and patient reported satisfaction was performed, evaluating preoperative clinical
factors significantly different between the two surgical methods or between the two time
cohorts. Factors identified as significant in univariate regression analysis were included in the
multivariate model. Statistical significance is defined as p<0.05 and all tests are two-sided.
The regional ethical board (REK 2015/892) has approved this study and all women have
given written consent to participation. The study is being presented according to the STROBE
guidelines [13].
Results
During the study period, 2006–2014 a total of 772 women were surgically treated with endome-
trial resection (75%) or endometrial ablation (25%) (Fig 1). A total of 468 patients were included
after consent. Of these 450 (96%) answered the questionnaire. The procedures included were
312 (67%) hysteroscopic resections of the endometrium (with or without resection of fibroids),
21 (4%) hysteroscopic resections of fibroids only, and 135 (29%) endometrial ablations.
Preoperative clinical characteristics are shown in Table 1.
The 303 women declining to participate were not different from the consenting women
regarding age (median 44 years, 95% CI 43–46, p = 0.753 Mann-Whitney). However, more
women treated by endometrial ablation (70%) consented to participate, compared with those
treated with hysteroscopic resection (58%, Fig 1).
Women treated with hysteroscopic fibroid resection only (n = 21) were younger, with a
median age of 40 years (95% CI 34–44) and with a lower median parity of 0.5 (95% CI 0–1,
both p�0.003, Kruskal-Wallis test) than women treated with hysteroscopic endometrial resec-
tion or endometrial ablation. In our further statistical analysis, the resections of fibroids only
are grouped together with the endometrial resections.
Women treated with endometrial ablation had a slightly thinner endometrium measured
by preoperative ultrasound and a lower rate of previous sterilization procedure than the hys-
teroscopic resection group. In spite of similar median age in the two groups, women treated
with endometrial resection had a significantly higher proportion of postmenopausal status
than in the endometrial ablation group.
Previous medical treatment to correct menorrhagia was reported in 310 (66%) of cases.
Medical treatment consisted of fibrinolytic inhibitors 158/310 (34%) and/or a hormone-releas-
ing intrauterine device (IUD) 148 (32%). Of postmenopausal women, 17/45 (38%) used any
hormonal replacement therapy.
Perioperative findings comparing the two minimally invasive treatments are shown in
Table 2. In total, there were significantly more complications in the hysteroscopic resection
group. Overall complication rate was significantly higher if fibroids were present: 16% versus
8% (p = 0.031 Chi-square test, data not shown).
In total 39 different surgeons performed the procedures during the 2006–2014 cohort. Four
of the surgeons were classified as experienced and performed 273 (58%) of the procedures, of
which 60% were hysteroscopies. Medium experienced surgeons performed 133 (28%) proce-
dures and the inexperienced performed 62 (13%) procedures, of which 46 (74%) were endo-
metrial ablations. The surgeons classified as inexperienced performed only 16 (5%) of the
hysteroscopic resections. There were no statistical significant differences in complication rates
among the different groups of surgeons, (p = 0.073).
Histopathologic examination of the hysteroscopic resectate detected malignancy in 2
(0.04%) women, one despite benign preoperative histological sample and one where preopera-
tive endometrial sample was missing. Both women had a hysterectomy performed during the
first postoperative month.
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The short-term and long-term postoperative variables were not significantly different when
comparing the two treatments (Table 3).
Only 20 women (4%) reported persistent bleeding disorder in the questionnaire, 15 after
hysteroscopic resection and 5 after endometrial ablation (p = 0.647 Chi-square test). We found
no significant difference in pain change amongst the endometrial resection and the endome-
trial ablation groups, irrespective of pre-existing dysmenorrhea.
The median follow-up time for the 2006-2014-cohort was 76 months (Fig 2A). During this
period, 54 (16%) women in the hysteroscopic resection group had a subsequent hysterectomy
Fig 1. Inclusion and exclusion flowchart. Inclusion and exclusion flowchart for women treated for abnormal uterine bleeding with minimally invasive surgery at
Haukeland University hospital during 2006–2014.
https://doi.org/10.1371/journal.pone.0219294.g001
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performed, compared with 11 (8%) women in the endometrial ablation group (p = 0.024). The
time until hysterectomy was median 15 months (95% CI 10–28) in the endometrial ablation
group, and 19 months in the hysteroscopy group (95% CI 6–38, p = 0.726). The proportion of
patients reporting satisfaction with the received treatment was identical for both treatments.
Surgeon experience did not significantly influence the rate of hysterectomy.
Regarding the preoperative clinical characteristics, the two time-cohorts differ only in a sig-
nificantly higher proportion of postmenopausal women and more myomas described preoper-
atively while fewer women were subjected to sterilization in the present cohort (2006–2014)
(Table 4).
Table 1. Preoperative clinical characteristics for women treated for abnormal menstrual bleeding. Comparison of two minimal invasive surgical methods performed
at Haukeland University hospital during 2006–2014.
Hysteroscopic resection n = 333
median (95% CIa)
Endometrial ablation n = 135
median (95% CI)
Mann-Whitney U test p-value
Age 44 (44–45) 44 (42–45) 0.079
Parityb 2 (2–2) 3 (2–3) 0.072
Bleeding days per monthc 10 (8–14) 10 (7–12) 0.759
Anteroposterior diameter uterusd (mm) 48 (47–49) 48 (46–50) 0.835
Transverse diameter uteruse (mm) 60 (58–62) 60 (57–64) 0.920
Endometrial heightf (mm) 9 (8–10) 8 (6–8) 0.024
Myoma diameterg (mm) 21 (20–23) 21 (11–40) 0.493
Cavity lengthh (cm) 9 (9–9) 9 (9–9) 0.222
Number (%) Number (%) Chi-square p-value
Menopausal status <0.001
Pre 291 (87) 132 (97)
Post 42 (13) 3 (3)
Myomai <0.001
Yes 126 (55) 14 (18)
No 103 (45) 62 (82)
Submucous myomaj 0.149
Yes 52 (41) 3 (21)
No 74 (59) 11 (79)
Dysmenorrhoeai 0.052
Yes 64 (30) 18 (19)
No 149 (70) 75 (81)
Previous sterilizationk 0.036
Yes 54 (20) 34 (30)











jOut of 140 cases noted as having any myoma n = number
kn = 85
https://doi.org/10.1371/journal.pone.0219294.t001
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Comparing perioperative data from the two different time-cohorts, the procedures during
2006–2014 were more often performed in general anesthesia rather than regional anesthesia,
had a shorter operation time and a lower complication rate (Table 5).
The questionnaire used to evaluate outcomes were answered by 96% of included patients in
our present cohort. The outcomes regarding early post-operative bleeding, pain and rate of sub-
sequent hysterectomy were similar when comparing the two time-cohorts (Table 6 and Fig 2B).
However, a higher proportion of women in the present cohort reported to be satisfied with the
procedure and more women became amenorrhoic, compared with the previous cohort.
When assessing the risk of subsequent hysterectomy after endometrial resection or ablation
we excluded cases with only myoma resection performed. Neither endometrial height, meno-
pausal status, presence of myomas nor former sterilization were of individual (univariate) statis-
tical significance. When adjusting for potential confounders (age at treatment and surgeon
experience), neither the new treatment modality (endometrial ablation) nor patient being
treated during the present cohort had any increased risk of subsequent hysterectomy (Table 7).
Assessing patient self-reported satisfaction only former sterilization was of statistical signifi-
cance when testing in univariate analysis. Neither age, surgeon experience nor complication
rates were significantly different. The rate of patients reporting to be satisfied with their sur-
gery was borderline higher in the 2006–2014 cohort with an OR of 1.77 (95% CI 1.03–3.03,
p = 0.040) adjusted for type surgery and sterilization status (S1 Table). Type surgery was not
independently a factor influencing patient satisfaction.
Discussion
Comparing the two time cohorts including 854 women treated with minimally invasive proce-
dures for abnormal uterine bleeding, we found a stable subsequent hysterectomy rate and a








Operation timec (minutes) 25 (23–26) 13 (12–15) <0.001





Number (%) Number (%) Fisher´s exact test, p-value
General anesthesia 317 (95) 133 (99) 0.117
Uterine perforation 14 (4) 0 (0) 0.013
Blood loss >500ml or need of treatmente 23 (7) 0 (0) 0.002
Fluid deficit >1000ml 14 (4) 0 0.013
Technical failuref 0 2
Total perioperative complication rate 43 (13) 2 (2) <0.001
aOne woman scheduled for endometrial ablation converted to hysteroscopic resection due to technical problems, thus 334 completed endometrial resections and 134
endometrial ablations are used for follow-up data.




e Defined as complication if surgeon initiated measures (such as intrauterine balloon tamponade or intravenous fibrinolytic medications) to control excessive bleeding
fDiscontinued procedure, 1 converted to hysteroscopic resection, 1 had a successfully completed ablation later same day.
n = number
https://doi.org/10.1371/journal.pone.0219294.t002
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slightly improved patient-reported satisfaction rate. Comparing the two minimally invasive
procedures, the endometrial ablation, despite being performed by less experienced surgeons,
was found to have fewer complications but a similar rate of patient-reported satisfaction and a
non-inferior subsequent hysterectomy rate compared with treatment by hysteroscopic
resection.
When introducing a new treatment modality it should lead to a benefit for the patients with
improved efficacy and/or reduced complication rate without increased use of resources.
A large Cochrane review from 2019, including 28 trials with a total of 4287 women, demon-
strated that endometrial ablation techniques (“second generation endometrial ablation”)
resulted in a similar improvement of abnormal uterine bleeding as hysteroscopic endometrial
ablation (“first generation endometrial ablation”) when measuring pictorial blood assessment
Table 3. Patient self-reported clinical characteristics after surgery for abnormal uterine bleeding during 2006–2014.






Mann-Whitney U test, p-value
Pain (days) 2 (1–3) 2 (2–3) 0.200
Bleeding (days) 6 (5–7) 7 (4–7) 0.635
Sick leave (days) 4 (3–7) 7 (3–7) 0.225
Long term post-operative
(>1 month)
n = 450 answered questionnaire
n (%) n (%) Chi-square test, p-value
Satisfiedc 0.955
Yes 270 (85) 112 (85)
No 49 (15) 20 (15)
Bleedingd 0.459
Reduced 227 (85) 101 (88)
Unchanged 29 (11) 6 (5)
Augmented 11 (4) 8 (7)
Amenorrhoic 0.646
Yes 130 (42) 54 (41)
No 179 (58) 77 (59)
Pain change dysmenorrhea groupe 0.520
Reduced/unchanged 23 (62) 8 (73)
Augmented 14 (38) 3 (28)
Pain change overallf 0.959
Reduced/unchanged 137 (77) 63 (77)




Yes 54 (16) 11 (8)
No 280 (84) 123 (92)
aOne woman scheduled for endometrial ablation converted to hysteroscopic resection due to technical problems, thus 334 completed endometrial resections and 134
endometrial ablations are used for follow-up data.





fn = 208, n = number
https://doi.org/10.1371/journal.pone.0219294.t003
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charts (PBAC)[8]. They reported an amenorrhea rate of 39% for both ablative techniques. We
found a 42% amenorrhea rate in our present cohort, no significant difference between endo-
metrial resection and endometrial ablation, but a significant improvement from the 27%
amenorrhea rate reported in our previous cohort. In the same review [8], the total patient-
reported satisfaction rate was equal at 91% for second generation and 90% for first generation
ablation techniques. We found an 85% satisfaction rate for both modalities in the present
cohort, showing a significant increase from 73% in our previous cohort.
Fig 2. Survival curves displaying rate of subsequent hysterectomy. Rate of subsequent hysterectomy after
hysteroscopic resection or endometrial ablation for 843 women treated during 1992–1998 and 2006–2014. A. Grouped
based on surgeon experience level. B. Grouped based on time-cohort and surgical technique.
https://doi.org/10.1371/journal.pone.0219294.g002
Table 4. Preoperative clinical characteristics for women treated for abnormal menstrual bleeding during two time periods. Women treated by hysteroscopic resec-








Mann-Whitney U test p-value
Age 44 (43–45) 44 (43–45) 0.269
Parityb 2 (2–3) 3 (2–3) 0.103
Bleeding days per monthc 10 (8–12) 9 (8–10) 0.078
Endometrial heightd (mm) 9 (8–9) 8 (8–9) 0.459
Cavity lengthe (cm) 9 (9–9) 9 (9–9) 0.272
Number (%) Number (%) Chi-square p-value
Menopausal status <0.001
Pre 423 (90) 380 (98)
Post 45 (10) 6 (2)
Myomaf 0.018
Yes 140 (46) 190 (55)





Yes 100 (33) 97 (30)
No 207 (67) 229 (70)
Previous sterilizationi <0.001
Yes 88 (23) 181 (64)
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Table 5. Perioperative data for women treated by minimal invasive procedures during two time cohorts. Women treated by hysteroscopic resection (n = 334) or








Operation timeb (minutes) 20 (19–22) 31 (30–35) <0.001
Number (%) Number (%) Fisher´s exact test, p-value
General anesthesia 450 (96) 126 (33) <0.001
Uterine perforation 14 (3) 31 (8) 0.001
Blood loss >500ml or need of interventionc 23 (5) 25 (6) 0.890
Fluid deficit >1000ml 14 (3) 22 (6) 0.049
Total procedures with any major complication 45 (10) 69 (18) <0.001
aCI = confidence interval
cases missing
bn = 15
cDefined as complication if surgeon initiated measures (such as intrauterine balloon tamponade or intravenous fibrinolytic medications) to control excessive bleeding,
n = number
https://doi.org/10.1371/journal.pone.0219294.t005
Table 6. Patient self-reported clinical characteristics after surgery for abnormal uterine bleeding, comparison of two cohorts.







Painb (days) 2 (2–2) 2 (0–2) 0.247
Bleedingc (days) 6 (5–7) 6 (5–7) 0.781
Sick leaved (days) 5 (3–7) 7 (7–7) <0.001
Long term post-operative
(>1 month)
n = 450 answered questionnaire
n (%) n (%) Chi-square test, p-value
Satisfiede <0.001
Yes 382 (85) 157 (73)
No 69 (15) 57 (27)
Amenorrhoicf <0.001
Yes 184 (42) 57 (27)
No 258 (58) 157 (73)
Persisting bleeding problemg 0.161
Yes 20 (4) 6 (2)
No 422 (96) 243 (98)
Subsequent hysterectomy 0.715
Yes 65 (14) 57 (15)
No 403 (86) 329 (85)
aCI = confidence interval
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The complication rates have been significantly reduced in the present cohort compared
with our previous cohort. Still, the overall hysteroscopic complication rate of 13% is substantial
compared with the rate of 0.81% found by Jansen in 2000 [14]. However these rates are not
directly comparable. In order not to underestimate complication rates, in both our cohorts, we
registered all procedures with a set volume of blood loss or fluid deficit as complications, while
the Jansen-study defined an event as complication only when leading to intervention. Perfora-
tion was noted in 8% of the hysteroscopies in our previous cohort and 4% in the present
cohort, the latter approaches the 1% risk noted in a study from 2007 of 600 procedures [15].
This study reported experienced surgeons only in contrast to only 58% of experienced sur-
geons in our present cohort. The Cochrane review from 2019 states a perforation rate of 1.3%
for hysteroscopic resection and 0.4% for endometrial ablation. The significantly reduced over-
all complication rate in our present cohort can probably be related to the introduction of the
less technically challenging and less risky radiofrequency endometrial ablation technique.
We found a 12 minutes significantly shorter operation time in the endometrial ablation
group compared with the hysteroscopic resection groups. This is supported by the 2019
Cochrane review reporting a median reduction of 13.5 minutes when using endometrial abla-
tion techniques [8]. We also acknowledge that the hysteroscopic procedure requires more pre-
operative theatre time for instrument set-up, while the radiofrequency ablation instrument is
more easily prepared. Unfortunately, we had not recorded data of the total theatre time in our
two cohorts, and cannot estimate the impact of this assumed added benefit.
Subsequent hysterectomy rate of 16% for a hysteroscopic resection compared with 8% for
endometrial ablation is in favor of the latter. Similar rates are reported in a Finnish long-term
follow-up after endometrial ablation and in a study of endometrial ablation for patients diag-
nosed with adenomyosis, both with a subsequent hysterectomy rate of 19% [16, 17]. Similar
pattern of difference was also found in the 2019 Cochrane review regarding hysterectomy at 2-
5years; 19% after hysteroscopy versus 16% after endometrial ablation [8].
However, in our logistic regression, accounting for potential confounders, we did not find
endometrial ablation to independently neither increase nor decrease the risk of subsequent
hysterectomy as compared to hysteroscopic resection.
We found no significant difference in reduced pain between the hysteroscopic resection
and the endometrial ablation group, irrespective of pre-existing dysmenorrhea. This supports
a study of radiofrequency ablation treatment for adenomyosis, noting a significant decrease in
dysmenorrhea rate in 47% of their patients [17]. Also, this finding challenges a tradition of not
Table 7. Prediction of risk of subsequent hysterectomy after minimal invasion surgery for bleeding disorders. Uni- and multivariate logistic regression for 823
patients treated at Haukeland University Hospital 1992–1998 and 2006–2014.
Variable n Univariate OR 95% CI p-value Multivariate OR 95% CI p-value
Age at treatment (years) 823 0.95 0.92–0.98 0.003 0.95 0.92–0.98 0.001
Cohort treated 0.581 0.389
1992–1998 375 1 1
2006–2014 448 0.90 0.61–01.3 1.20 0.79–1.82
Type surgery 0.025 0.103
Endometrial ablation 135 1 1
Hysteroscopic resection 688 2.10 1.1–4.02 1.8 0.89–3.70
Surgeon experience 0.004 0.027
Inexperienced 71 1 1
Moderate/Experience 252 6.36 1.54–26.29 5.19 1.21–22.35
n: number of patients, OR: odds ratio
https://doi.org/10.1371/journal.pone.0219294.t007
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choosing endometrial ablation for patients with preoperative substantial dysmenorrhea. We
acknowledge that as fibroids distorting the cavity was an exclusion criteria only for endome-
trial ablation, and the complication rate for hysteroscopic resection when fibroids are present
are higher, some of the difference in outcome and satisfaction rates might be accounted for by
this difference in patient population. However, our patient files are not standardized regarding
description of myomas and their relation to the uterine cavity, thus we did not exclude patients
from our hysteroscopic resection group based on this criterion. However the rate of reported
submucous myoma was not significant different between the groups subjected to hystero-
scopic resection versus endometrial ablation. Still the hysteroscopy group and the cohort oper-
ated 2006–2014 were noted with higher rates of myomas, in the univariate logistic regression
neither myomas in total or submucosal location was identified of significance in affecting rate
of neither subsequent hysterectomy nor patient satisfaction.
Our two time-cohorts are largely comparable, but differ in some aspects. The present
cohort has a significantly higher proportion of postmenopausal women, 45 (10%) versus six
(2%) in the previous cohort. Except for contributing to a generally higher rate of achieving
amenorrhea in the present cohort, we do not see this difference as an important confounder.
Tested in logistic regression it was not of statistical significance in relation to hysterectomy
rate nor patient satisfaction.
Surprisingly, we found that 2% of women treated with endometrial ablation were postmen-
opausal, not in accordance with our department guidelines. This treatment modality is not
intended for postmenopausal women, and might be a potentially dangerous intervention
when it comes to evaluation for malignancy.
In the present cohort, 19% of the women had a prior sterilization procedure, in contrast to
50% in our previous cohort. This difference is probably due to a substantial increase in patient
cost for sterilization procedures, introduced in Norway in 2002. From approximately 20 Euro
(NOK 193) before 2002 to 635 Euro (NOK 6079) after, leading to a decline in female steriliza-
tion rate by more than 70% [18]. Although women with a former sterilization reported higher
patient satisfaction in univariate regression analysis this factor was no longer significant in the
multivariate model. We therefore do not consider the reduction of sterilization as an impor-
tant confounder regarding outcomes from the minimally invasive procedures.
In two women, histopathologic examination of the resectate detected malignancy. The risk
of endometrial cancer has been estimated as 0.33% for women with premenopausal abnormal
bleeding [19] and 9% for women with postmenopausal bleeding [20]. With a considerable
higher risk of endometrial cancer amongst women with postmenopausal bleeding, we consider
hysteroscopic procedure yielding histologic tissue for histopathologic examination as the pre-
ferred modality for these women. It has been disputed whether hysteroscopy may cause intra-
peritoneal spread of malignant cells through the fallopian tubes, but this has been refuted [21].
The risk of finding malignant cells in hysteroscopic material calls for extra attention to have
fresh endometrial biopsies preoperatively and to choose endometrial ablation with caution
when treating women long time after menopause.
The main limitation of this study is that it is a non-randomized, retrospective single-center
study. Furthermore, we lack PBAC-scores for objective evaluation of the bleeding patterns, but
we include patient-reported outcomes regarding change in bleeding. The overall response rate
in this newest cohort was 60%, which is significantly lower than the 85% participation rate in
our former study cohort. Women treated by hysteroscopic resection had a significantly lower
response rate than those treated by endometrial ablation. Whether this influence the patient
reported treatment satisfaction rate we do not know. If those less satisfied opt out of answer-
ing, this may mask a difference in patient reported satisfaction between the different proce-
dures. Similarly if those opting out have a higher rate of failure (need of further treatment) this
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may also mask a reported difference between the two methods, although for the participating
women we do not find any difference regarding satisfaction or subsequent hysterectomy.
We have tried to evaluate the impact of relevant confounding factors: age, menopausal
status, sterilization status, endometrial thickness, presence of myomas and surgeon experience
by performing multivariate logistic regression analysis. Of these factors only higher age
independently decreased risk of subsequent hysterectomy while women treated by surgeons
of moderate to high experience somewhat surprisingly had a higher rate of further surgery.
We assume this is related to more “complex” patients (as noted with higher rates of myomas
and slightly thicker endometrium) were allocated to hysteroscopic resection by experienced
surgeons while junior doctors using endometrial ablation treated the less complicated
patients.
The strength of our study is the relatively large patient cohorts regarding the total number
of hysteroscopic resections and endometrial ablations, and a long follow-up including patient
reported outcomes performed similarly in two different time-periods. Surgeons were not spe-
cifically assigned to participate in this study when performing the procedures. Therefore, our
findings reflect a success- and complication rate to be expected in everyday surgical practice.
Our study includes outcome in relation to surgeon experience and highlights the fact that less
surgical experience has no impact on complication or satisfaction rate for non-hysteroscopic
endometrial ablation. Our hospital is a tertiary hospital serving 10% of the Norwegian popula-
tion, and we assume that our cohort is representative for the average Norwegian female popu-
lation. The validity of our study is considered to extend at least to the other Nordic countries,
as the populations and the quality of health services are similar. All together, we consider that
our findings are clinically meaningful and may have direct implication on surgical practice.
Thus, complementing hysteroscopic treatment for abnormal bleeding by an endometrial abla-
tion procedure has been evaluated as beneficial in a routine clinical setting.
Conclusions
After introduction of endometrial ablation as a supplement to hysteroscopic resection, the
complication rate and operation time in our department has declined, compared with a previ-
ous cohort of hysteroscopic resection. Although demanding less surgeon experience, the
patient reported outcomes were slightly better and the subsequent hysterectomy rate non-
inferior for patients operated during 2006–2014 when endometrial ablation was part of
routine treatment for abnormal uterine bleeding. When medical treatment is not feasible,
endometrial ablation may be a good alternative to hysteroscopic resection in properly selected
patients.
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Endometrial Ablation in Finland: Cancer Risks and Later Hysterectomies. Obstet Gynecol. 2017; 130
(3):554–60. https://doi.org/10.1097/AOG.0000000000002166 PMID: 28796675
17. Philip CA, Le Mitouard M, Maillet L, de Saint-Hilaire P, Huissoud C, Cortet M, et al. Evaluation of Nova-
Sure. Eur J Obstet Gynecol Reprod Biol. 2018; 227:46–51. https://doi.org/10.1016/j.ejogrb.2018.04.
001 PMID: 29886317
18. Guide to the sterilization law. (Lov om sterilisering-Veileder til lov og forskrift. IS-2024). Healt Depart-
ment Norway; 2012.
19. Pennant ME, Mehta R, Moody P, Hackett G, Prentice A, Sharp SJ, et al. Premenopausal abnormal uter-
ine bleeding and risk of endometrial cancer. BJOG. 2017; 124(3):404–11. https://doi.org/10.1111/1471-
0528.14385 PMID: 27766759
20. Clarke MA, Long BJ, Del Mar Morillo A, Arbyn M, Bakkum-Gamez JN, Wentzensen N. Association of
Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-
analysis. JAMA Intern Med. 2018; 178(9):1210–22. https://doi.org/10.1001/jamainternmed.2018.2820
PMID: 30083701
21. Chang YN, Zhang Y, Wang YJ, Wang LP, Duan H. Effect of hysteroscopy on the peritoneal dissemina-
tion of endometrial cancer cells: a meta-analysis. Fertil Steril. 2011; 96(4):957–61. https://doi.org/10.
1016/j.fertnstert.2011.07.1146 PMID: 21872230
Endometrial ablation long-term outcome of two treatment modalities
PLOS ONE | https://doi.org/10.1371/journal.pone.0219294 July 10, 2019 16 / 16
